Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Spironolactone 20mg/5ml / Chlorothiazide 200mg/5ml liquid
0202040S0AAAFAF
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 20mg/5ml oral liquid
0202030S0AADDDD
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 2mg/5ml oral liquid
0202030S0AADUDU
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3.3mg/5ml oral liquid
0202030S0AADXDX
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3.5mg/5ml oral liquid
0202030S0AADTDT
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 30mg/5ml oral liquid
0202030S0AACUCU
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 35mg/5ml oral liquid
0202030S0AADGDG
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3mg / Chlorothiazide 30mg capsules
0202040S0AAAMAM
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 3mg/5ml oral liquid
0202030S0AADMDM
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 4.5mg/5ml oral liquid
0202030S0AADLDL
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 40mg/5ml oral liquid
0202030S0AADIDI
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 4mg / Chlorothiazide 40mg capsules
0202040S0AAAHAH
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 4mg/5ml oral liquid
0202030S0AACWCW
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 5mg / Chlorothiazide 50mg capsules
0202040S0AAAPAP
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 5mg/5ml / Chlorothiazide 50mg/5ml liquid
0202040S0AAAKAK
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 6.25mg/5ml oral liquid
0202030S0AACTCT
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 6mg / Chlorothiazide 60mg capsules
0202040S0AAARAR
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 6mg/5ml oral liquid
0202030S0AADQDQ
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 7.5mg/5ml oral liquid
0202030S0AACVCV
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 75mg/5ml oral liquid
0202030S0AADEDE
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 7mg/5ml oral liquid
0202030S0AACYCY
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 8.3mg/5ml oral liquid
0202030S0AADVDV
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 8mg/5ml oral liquid
0202030S0AADBDB
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spirospare 100 tablets
0202030S0BJACAV
|
Spirospare | Spironolactone | Cardiovascular System | No data available |
|
SpiroTect antibacterial cassette duo
20050300271
|
SpiroTect antibacterial cassette duo | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.